Stockreport

LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024

LENZ Therapeutics, Inc.  (LENZ) 
PDF SAN DIEGO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial stage biopharmaceutical company focuse [Read more]